MORRIS PLAINS, N.J., Sept. 15, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, is scheduled to present at the 2010 UBS Global Life Sciences Conference at 8:00 a.m. on Wednesday, September 22, 2010, at the Grand Hyatt Hotel in New York City. The presentation, which can be downloaded simultaneously at http://www.immunomedics.com/1aboutus/present.pdf, will provide a corporate overview.
